These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 3569865)
21. The INS B allele (1,428 Fok I) is associated with reduced IDDM incidence in autoantibody-positive first degree relatives despite the presence of autoantibodies and high-risk HLA alleles. Pugliese A; Awdeh ZL; Alper CA; Jackson RA; Eisenbarth GS Transplant Proc; 1995 Dec; 27(6):3392. PubMed ID: 8540014 [No Abstract] [Full Text] [Related]
22. Segregation analysis of two genetic markers in IDDM families under two-locus models. Dizier MH; Clerget-Darpoux F; Hochez J Genet Epidemiol; 1989; 6(1):71-5. PubMed ID: 2567261 [TBL] [Abstract][Full Text] [Related]
23. HLA and genetics of IDDM. Holism vs. reductionism? Segall M Diabetes; 1988 Aug; 37(8):1005-8. PubMed ID: 3292321 [TBL] [Abstract][Full Text] [Related]
24. The effect of association of genetic factors on relative risk. Falk CT; Rubinstein P Ann Hum Genet; 1980 Jan; 43(3):295-301. PubMed ID: 7362205 [TBL] [Abstract][Full Text] [Related]
25. Molecular approaches to the relationships between HLA and susceptibility to diseases. Degos L; Khalil I; Blanchet O; Lepage V; Paul P; Hors J Adv Nephrol Necker Hosp; 1992; 21():13-22. PubMed ID: 1566643 [No Abstract] [Full Text] [Related]
26. Localization of central MHC genes influencing type I diabetes. Cheong KY; Allcock RJ; Eerligh P; Witt CS; Christiansen FT; McCann V; Price P Hum Immunol; 2001 Dec; 62(12):1363-70. PubMed ID: 11756005 [TBL] [Abstract][Full Text] [Related]
27. Heterogeneity of HLA genetic factors in IDDM susceptibility. Martell M; Marcadet A; Moine A; Boitard C; Deschamps I; Dausset J; Bach JF; Cohen D Immunogenetics; 1990; 31(4):233-40. PubMed ID: 1970333 [TBL] [Abstract][Full Text] [Related]
28. Insulin-dependent diabetes mellitus: a model for the study of multifactorial disorders. Field LL Am J Hum Genet; 1988 Dec; 43(6):793-8. PubMed ID: 3195582 [No Abstract] [Full Text] [Related]
29. Comprehensive human leukocyte antigen genotyping of patients with type 1 diabetes mellitus in Taiwan. Tung YC; Fann CS; Chang CC; Chu CC; Yang WS; Hwu WL; Chen PL; Tsai WY Pediatr Diabetes; 2018 Jun; 19(4):699-706. PubMed ID: 29383806 [TBL] [Abstract][Full Text] [Related]
30. The insulin gene and susceptibility to IDDM. Cox NJ; Spielman RS Genet Epidemiol; 1989; 6(1):65-9. PubMed ID: 2567260 [TBL] [Abstract][Full Text] [Related]
32. The effects of reduced fertility, method of ascertainment, and a second unlinked locus on affected sib-pair marker allele sharing. Risch N Am J Med Genet; 1983 Oct; 16(2):243-59. PubMed ID: 6580817 [TBL] [Abstract][Full Text] [Related]
33. Juvenile diabetes mellitus and the HLA system. Suciu-Foca N; Rubinstein P; Nicholson J; Susinno E; Weiner J; Godfrey M; Hardy M; Rayfield E; Reemtsma K Transplant Proc; 1979 Jun; 11(2):1309-13. PubMed ID: 473359 [No Abstract] [Full Text] [Related]
34. HLA antigens and susceptibility to juvenile diabetes: do additive relative risks imply genetic heterogeneity? Curie-Cohen M Tissue Antigens; 1981 Feb; 17(2):136-48. PubMed ID: 7233414 [TBL] [Abstract][Full Text] [Related]
35. HLA-DR effects in a large German IDDM dataset. Field LL; Fothergill-Payne C; Bertrams J; Baur MP Genet Epidemiol Suppl; 1986; 1():323-8. PubMed ID: 3471665 [TBL] [Abstract][Full Text] [Related]
36. Shared genetic susceptibility of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus: contributions of HLA and haptoglobin. Rich SS; Panter SS; Goetz FC; Hedlund B; Barbosa J Diabetologia; 1991 May; 34(5):350-5. PubMed ID: 1864490 [TBL] [Abstract][Full Text] [Related]
37. [Polymorphism of C4 and factor B in type I diabetes]. Blickle JF; Hauptmann G; Goetz J; Tongio MM; Mayer S; Brogard JM; Dorner M Pathol Biol (Paris); 1988 Jun; 36(6):791-4. PubMed ID: 3047638 [TBL] [Abstract][Full Text] [Related]